What JPT Peptide Techologies does

JPT Peptide Technologies GmbH is a Berlin-based, privately held peptide manufacturing company founded in 2004 and operating as a subsidiary of BioNTech. The company specializes in synthetic peptide products and services for immunology, immunotherapy, cell therapy, and proteomics research, serving academic institutions, pharmaceutical companies, government agencies (including NIH/NCI), and biotech firms across North America, Europe, and emerging markets. JPT operates a B2B-only model, explicitly excluding private individuals from its customer base, with revenue generated through a mix of fixed-price e-commerce catalog sales (typically US$165–$960 per item) and quote-based custom synthesis and clinical-grade orders. North American sales are supported through a dedicated US phone line and business development email channel.

The company's core technology platform centers on proprietary SPOT ultra-high throughput peptide synthesis, the PepMix peptide pooling system, the QTag absolute quantification method, and high-density PepStar microarrays, all protected by registered trademarks and 20+ years of patented manufacturing know-how. The product portfolio spans overlapping peptide pools (PepMix), positional scanning libraries (PepMaster), antigen discovery pools (SpotMix), reference peptides for targeted proteomics (SpikeTides), clinical-grade peptides and pools for cell therapy and IND-grade applications, custom peptide synthesis at micro to large scale, and a broad modifications portfolio including biotinylation, cyclization, fluorescent labeling, and post-translational modifications. Quality is underpinned by ISO 9001:2015 certification (TÜV Rheinland, annual since 2004) and AEO customs certification, with clinical-grade production meeting regulatory documentation standards for cell therapy and immunotherapy customers.

JPT serves six primary customer segments including cell therapy and immunotherapy developers, immune monitoring and diagnostics researchers, proteomics research laboratories, infectious disease researchers, cancer immunotherapy developers, and autoimmune/allergy researchers. The company is recognized as a major global supplier alongside Miltenyi Biotec, GenScript, and Thermo Fisher, with over 1,000 peer-reviewed publications citing its products. Distribution is direct via an e-commerce platform, formal quote request workflow, and global technical support, with named customers spanning Baylor College of Medicine, Yale, UCL, Charité Berlin, Université de Montréal, University of Cambridge, University of Toronto, and Memorial Sloan Kettering Cancer Center. No revenue is publicly disclosed.

Name

JPT Peptide Techologies

Legal name

JPT Peptide Technologies GmbH

Website

https://jpt.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

JPT Peptide Technologies GmbH is a Berlin-based, BioNTech-owned manufacturer of synthetic peptides, peptide pools, microarrays, and clinical-grade peptide products serving academic, pharmaceutical, and biotech customers in immunotherapy, cell therapy, immune monitoring, and proteomics research.

Ownership category

akta.pro rank

Product category

Peptide Synthesis Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Therapeutic Peptides & Protein/Peptide Biologics (HLAAAAAH)

Keywords

• Custom peptide synthesis
• Peptide pools
• Peptide microarrays
• Proteomics reagents
• Immunotherapy peptides

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Catalog Peptide Products: Predefined peptide products with fixed prices sold through the online catalog including individual peptides, peptide pools, libraries, and microarrays. Revenue generated through direct online purchasing with prices ranging from approximately $165 to $958 per product item.
2. Custom Peptide Synthesis Services: Bespoke peptide manufacturing based on customer specifications including custom purity levels, modifications, lengths, and pooling configurations. Priced through quote requests with 20-30 day payment terms.
3. Clinical Grade Peptides: Higher regulatory standard peptides for immunotherapy, cell therapy, and clinical immune monitoring with enhanced quality documentation including batch documentation, CoA according to IND requirements, and optional certified vials.
4. T Cell Assay Services: ELISpot and other T cell assay services including project design assistance, peptide library design, bioinformatics, and professional data analysis and reporting.
5. Proteomics Peptides and Kits: Specialized peptides for proteomics applications including SpikeTides reference peptides, SpikeMix pools, and absolute quantified peptides for mass spectrometry-based protein quantification.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

JPT Peptide Technologies manufactures and sells specialty peptide-based reagents and synthesis services for immunotherapy, immunology, and proteomics research. The portfolio spans PepMix peptide pools, PepStar peptide microarrays, PepTrack and PepMaster peptide libraries, SpikeTides stable-isotope-labeled reference peptides, SpotMix antigen discovery pools, and clinical-grade peptides, supported by custom peptide synthesis with 25+ modifications. The company serves pharmaceutical/biotech companies, research institutions, and universities worldwide from its ISO 9001:2015-certified Berlin laboratories, with explicit policy against serving private individuals.

Product overview

JPT Peptide Technologies is a specialized peptide manufacturing company offering a comprehensive portfolio of peptide-based products and services for immunology, cell therapy, vaccine development, and proteomics research. The company's offerings span core product lines including PepMix™ Peptide Pools (overlapping peptide pools for T-cell stimulation), PepStar™ Peptide Microarrays (high-density arrays for antibody profiling), PepTrack™ Peptide Libraries (custom libraries for epitope discovery), and SpikeTides™ TQL/TQL PLUS (absolute quantified peptides for proteomics). Additional key products include the PepMaster™ Positional Scanning Peptide Library, SpotMix™ Antigen Discovery Pools for rapid screening, and Clinical Peptides & Pools for immunotherapy applications. The company also provides Custom Peptide Synthesis services at various scales and purities, comprehensive Peptide Modifications (biotinylation, cyclization, fluorescent labeling, etc.), SpikeMix™ Reference Peptide Pools for targeted proteomics, and T Cell Assay Services including ELISpot. JPT operates under ISO 9001:2015 certification and is headquartered in Berlin, Germany.

Differentiator

Problem solved

Functional benefit

Brands

• PepMix™: Antigen-spanning peptide pools for T-cell stimulation and immune monitoring
• PepStar™
• PepTrack™
• SpotMix™
• SpikeTides™
• SpikeMix™
• PepMaster™
• BioTides™
• PepSequencer
• PepSup™
• PepSpots™
• Pan Select PepMix™

Products and services

• PepMix Peptide Pools Overlapping peptide pools covering viral or tumor antigens for antigen-specific T-cell stimulation in T cell assays, ELISpot, cytokine staining, cell-mediated cytotoxicity, proliferation assays, dendritic cell pulsing, and immune monitoring, sold as catalog product lines including PepMix for Infectious Disease Antigens, PepMix for Tumor Associated Antigens, PepMix Ultra Pools, PepMix Collections, and Pan Select PepMix.
• PepStar Peptide Microarrays High-density peptide microarrays for large-scale antibody profiling, epitope mapping, and serological screening in infectious disease, cancer, and autoimmune research.
• PepTrack Peptide Libraries Customized peptide libraries with flexible layout and specifications optimized for deep T-cell epitope discovery using ELISpot and intracellular cytokine staining assays.
• SpikeTides TQL / TQL PLUS Absolute Quantified Peptides Absolute quantified peptides incorporating the proprietary QTag technology for accurate protein quantification in mass spectrometry-based targeted proteomics workflows (SRM, MRM, PRM), supplied as SpikeTides TQL and SpikeTides TQL PLUS variants.
• PepMaster Positional Scanning Peptide Library Positional scanning peptide library containing 181 different peptide mixtures used to identify stimulating peptides for T-cell clones, where each mixture contains 9mer peptides with a single fixed amino acid position.
• SpotMix Antigen Discovery Pools Small-scale overlapping peptide pools synthesized using JPT's proprietary ultra-high throughput SPOT technology for antigen target discovery, T-cell epitope discovery, and biological screening.
• Clinical Peptides & Pools Clinical-grade peptides and PepMix pools produced under strict quality regulations for immunotherapy, cell therapy, clinical immune monitoring, and vaccine development, available as ISO PLUS or Clinical Grade specifications with full batch documentation and IND-ready Certificates of Analysis.
• Custom Peptide Synthesis Tailored peptide synthesis service offering micro-scale (10-50 nmol), intermediate (1-100 mg), and large-scale (>1 g) synthesis with customizable purity from crude to >95%, 25+ specialty modifications, and quantity-tiered options.
• SpikeMix Reference Peptide Pools Stable-isotope-labeled reference peptide pools enabling relative protein quantification in mass spectrometry-based targeted proteomics assays.
• PepSpots Peptides on Cellulose Peptide arrays synthesized directly on cellulose membrane supports for high-throughput screening and epitope mapping applications.
• T Cell Assay Services Comprehensive T cell assay services including ELISpot for immunogenicity testing, T cell epitope discovery, neo-epitope qualification, and antigen discovery with full project support from design through bioinformatics and professional data analysis and reporting.
• Immune Monitoring Services Comprehensive immune monitoring services for cellular and humoral immune response profiling to support clinical trials and immunotherapy development.

Quantifiable outcome

• 94% response rate in virus-specific T cell therapy using Clinical Grade PepMix pools in transplant patients
• +3 more outcomes

Named customers10 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Six partnerships are on record, tiered core and minor.

• BioNTechcoreStrategic or Co-development PartnerJPT Peptide Technologies is a subsidiary of BioNTech. The privacy policy states 'This may involve the processing of personal data by other group companies and providers on behalf of BioNTech.' The partnership represents a significant strategic alignment within the BioNTech group of companies, indicating close integration in operations and potential synergies in immunotherapy and vaccine development.
• TÜV RheinlandminorOthersAnnual audit and certification partner for ISO 9001:2015 quality management system. TÜV Rheinland conducts yearly review and certification of JPT's quality management system.
• CleverReach GmbH & Co. KGminorOthersEmail service provider for newsletter creation and distribution. JPT uses CleverReach to create and send newsletters to customers and subscribers. A data processing agreement is in place ensuring CleverReach does not use customer data for its own purposes.
• Unzer GmbHminorOthersPayment service provider for credit card processing in the online shop. Credit card information is entered in store and forwarded to Unzer for processing, ensuring payment data is not stored at JPT's webshop.
• Association of Biomolecular Resource Facilities (ABRF)coreStrategic or Co-development PartnerCollaborative development of ABRF cross-species SpikeMix Peptide Pool with ABRF standard proteomic research group (sPRG). The resulting product was qualified in more than 52 proteomics labs around the globe, demonstrating successful academic-industry partnership for proteomics standards development.
• US Government AgenciescoreStrategic or Co-development PartnerJPT products used in NIH and other government-funded research programs. National Cancer Institute researchers use JPT peptides for clinical trial evaluations. Baylor College of Medicine, which receives government funding, collaborates on cell therapy development with JPT products.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• AAPPTec: AAPPTec is a niche peptide synthesis equipment, reagents, and custom synthesis provider. It competes with JPT in custom peptide services and adjacent reagents, though with a smaller catalog scale focused on specialist research customers.
• ProteoGenix: ProteoGenix is a French biotech offering custom peptide synthesis and antibody services with growing focus on therapeutic peptide and protein production. It is a smaller-scale emerging competitor overlapping with JPT's custom and therapeutic-grade peptide work.

Direct peers

• GenScript: GenScript offers custom peptide synthesis alongside gene synthesis and cell therapy services. It is explicitly identified in JPT's market data as a key global peptide supplier and competes head-to-head in custom synthesis and T-cell reagent pools.
• Cambridge Research Biochemicals: Cambridge Research Biochemicals is a UK-based custom peptide synthesis and antibody specialist with overlapping customer types (academic and pharma research). It competes with JPT in custom peptides, modifications, and conjugated peptide offerings.
• Bachem: Bachem is a publicly listed specialist peptide manufacturer serving pharmaceutical and clinical customers with custom synthesis and GMP/clinical-grade peptides. It is a direct comparable in scale and regulatory capability to JPT's clinical-grade production line.
• PolyPeptide Group: PolyPeptide Group is a publicly listed GMP peptide manufacturer serving pharma customers. It competes with JPT in clinical- and commercial-grade peptide supply, particularly for therapeutic peptide and conjugate applications.
• Vivitide: Vivitide (formerly Peptides International) is a US-based specialty peptide manufacturer with catalog, custom, and GMP capabilities. It competes directly with JPT in custom peptide synthesis and clinical-grade peptide supply.
• Miltenyi Biotec: Miltenyi Biotec is a leading cell therapy and immunology reagent provider, explicitly named alongside JPT as a key global peptide-pool supplier. It overlaps heavily with JPT's PepMix products for T-cell stimulation and clinical immune monitoring.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher is the largest life-science tools company and is explicitly cited in JPT's market data as a top global peptide-pool competitor. It competes via its Pierce, PeproTech, and mass spectrometry reagent lines and can bundle peptides into broader procurement contracts.
• Bio-Techne: Bio-Techne (including its ProteinSimple and R&D Systems brands) is a diversified life-science tools provider with peptide reagents, proteomics kits, and immunology assays. It overlaps with JPT across proteomics and immune-monitoring product lines as part of a much broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/jpt
• Facebookfacebook.com/jpt.peptide.technologies
• LinkedInlinkedin.com/company/jpt-peptide-technlologies
• Xx.com/jpt_peptides

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JPT Peptide Techologies